Aaron I. Davis, Director, 10% Owner at Mirati Therapeutics, Inc. (MRTX), sold 75,000 shares at $52.20 ($3.5M) on 2019-01-08, disclosed to the SEC on 2019-01-09.
Open-market sale of $3.5M MRTX by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.47 | 16,643 | $757K | 21.5% |
| 2 | $45.47 | 16,643 | $757K | 21.5% |
| 3 | $46.29 | 8,357 | $387K | 11.0% |
| 4 | $46.29 | 8,357 | $387K | 11.0% |
| 5 | $47.48 | 15,000 | $712K | 20.2% |
| 6 | $52.20 | 5,000 |
| $261K |
| 7.4% |
| 7 | $53.40 | 5,000 | $267K | 7.6% |
| Total | $47.03 avg | 75,000 | $3.5M | 100% |
| Filing → |
| TYRA | SELL | 2023-02-13 | $4.4M | — | Filing → |
| RAIN | BUY | 2022-11-08 | $11.3M | — | Filing → |
| ITOS | SELL | 2022-05-11 | $20.2M | — | Filing → |